Éva Anna Pirosa, Andrea Grósz, János Tibor Kis, László Schandl, László Kautzky
Aim: Comparing the usage of a disposable prím-A-portTM with the classic insulin dosage method, after adding several dose of insulin to get the licence for distribution. Without the licence the usage of the prím-A-portTM device is qualified as “off label use”.
Methods: Level III evidences are required during official licensing: 15-20 individual treatment data and non-significant result. Twenty adult patients, with 1 type diabetes mellitus, were invited in the prospective study. The patients on a voluntary basis were assigned to the two following treatment methods for three weeks. 1; classic insulin dosage method 2; usage of prím-A-portTM. Regular human or fast-acting and glargine-insulin were dosed with the same device in the 2nd group. The results were evaluated by the measure of fructosamine and with questionnaires.
Results: 66.6% of the patients declared that prím-A-portTM facilitated the treatment. The authors examined the changing in the levels of fructosamine in both groups. They used “t-test”. No significant difference was observed. The cumulative frequency distribution is p=0.892.
Conclusions: This study shows the utility and the efficacy of prím- A-portTM in charge several dose of insulin, moreover proves it as an alternative form of the classic insulin dosage method. 10 pinpricks needed instead of 150 monthly.
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi